Introduction {#s1}
============

Riboswitches are *cis*-regulatory RNA elements that recognize and respond to defined external signals to affect transcription or translation of downstream messenger RNAs (mRNAs) ([@bib4]; [@bib39]; [@bib40]). Riboswitches generally consist of two domains: a sensory or aptamer domain and a regulatory domain or expression platform. The expression platform can adopt different conformations in response to ligand binding to the aptamer, and in this way control gene expression outcome ([@bib4]). The aptamer of each riboswitch class contains conserved sequence motifs and unique secondary or tertiary structural elements that help distinguish and bind specific ligands ([@bib31]). Bacterial T-box riboswitches represent a unique class of riboswitches that do not bind small molecule ligands, instead they recognize and bind tRNA molecules and sense directly their aminoacylation state ([@bib49]). T-box riboswitches serve as excellent paradigms to understand RNA-RNA interactions and RNA-based regulation.

T-box riboswitches are found in Gram-positive bacteria and are usually located in the region upstream of mRNA sequences encoding aminoacyl tRNA synthetases and proteins involved in amino acid biosynthesis and transport and hence participate directly in amino acid homeostasis ([@bib49]). In general, the aptamer domain of all T-box riboswitches contains a long stem, Stem I, responsible for specific tRNA binding ([@bib35]). The expression platform can adopt either a terminator or anti-terminator conformation, depending on whether the bound tRNA is charged or uncharged ([@bib24]; [@bib49]). In most T-box riboswitches, binding of a charged tRNA to the T-box leads to rho independent transcription termination whereas an uncharged tRNA stabilizes the anti-terminator conformation and leads to transcription read-through ([@bib24]; [@bib49]). Whereas Stem I and the anti-terminator domain are highly conserved among T-box riboswitches, the region connecting them can vary. The *Bacillus subtilis glyQS* T-box riboswitch, involved in glycine regulation, represents one of the simplest T-box riboswitches ([@bib20]) in which only a short linker and a small stem, Stem III, connect Stem I and the anti-terminator domain ([Figure 1](#fig1){ref-type="fig"}).

![Secondary and tertiary structures of *B. subtilis glyQS* T-box riboswitch and tRNA^Gly^.\
(**A**) Secondary structure diagrams of the *B. subtilis glyQS* T-box riboswitch and *B. subtilis* tRNA^Gly^ used in this study. Green and orange lines indicate interactions between the T-box specifier loop and the tRNA anticodon and between the T-box t-box sequence and the tRNA 3' NCCA, respectively. For the *glyQS* T-box sequence, the nucleotides in red were added for surface immobilization. (**B**) Ribbon diagram of a model of a complex between the *B. subtilis glyQS* T-box riboswitch (blue) and *B. subtilis* tRNA^Gly^ (green) based on SAXS data ([@bib8]). Distances between the 5' and 3' ends of the T-box and the 5' end of the tRNA^Gly^ are shown (black dash lines). The NCCA sequence at the 3' end of the tRNA is shown in light green and the t-box sequence in the T-box is shown in yellow.](elife-39518-fig1){#fig1}

Recognition of tRNA by a T-box riboswitch involves three main structural elements of the tRNA: the anticodon region, the 'elbow' region formed by the conserved T- and D-loops, and the 3' NCCA sequence ([Figure 1](#fig1){ref-type="fig"}). The anticodon and elbow regions of the tRNA interact with Stem I directly. Stem I contains several phylogenetically conserved structural motifs ([@bib35]), including a K-turn motif, a specifier loop, a distal bulge, and an apical loop ([@bib35]) ([Figure 1](#fig1){ref-type="fig"}). Bioinformatics and structural analyses have collectively revealed the interactions between Stem I and the tRNA ([@bib17]; [@bib30]; [@bib47]). Specifically, the co-crystal structures of Stem I/tRNA complexes show that Stem I flexes to follow closely the tRNA anticodon stem and interacts directly with the anticodon loop and the elbow through its proximal and distal ends, respectively ([@bib47]). The distal bulge and the apical loop fold into a compact structural module of interdigitated T-loops ([@bib6]; [@bib28]), which interact directly with conserved unstacked nucleobases at the tRNA elbow ([@bib17]; [@bib47]). In addition, the structures revealed that Stem I turns sharply around two hinge regions using a conserved dinucleotide bulge and the K-turn motif ([@bib18]; [@bib47]). Sensing of the aminoacylation state involves direct binding of the tRNA 3' end to a highly conserved bulge in the T-box, the t-box sequence ([@bib19]) ([Figure 1](#fig1){ref-type="fig"}). A free NCCA end can base pair with the t-box sequence, enabling the anti-terminator conformation, whereas a charged NCCA end prevents the formation of the NCCA/t-box interactions, leading to the more stable terminator conformation ([@bib24]; [@bib49]). Importantly, discrimination between the charged and uncharged tRNA does not require any additional proteins, such as EF-Tu ([@bib42]; [@bib48]), and is driven solely by RNA/RNA interactions.

While Small Angle X-ray Scattering (SAXS)-derived models of the entire *B. subtilis glyQS* T-box riboswitch in complex with tRNA are available ([@bib8]; [@bib11]), atomic-level structural details on the interactions between tRNA and the anti-terminator region are still lacking. In addition, there is a dearth of information on the kinetics of the binding process. Whereas it is clear that tRNA recognition involves several specific interactions, their binding temporal sequence remains elusive. In addition, it is unclear whether sensing of the 3' end of the tRNA involves any additional conformational changes in the T-box. Here, by introducing donor-acceptor fluorophore pairs at several locations in the tRNA and the T-box riboswitch, and using single-molecule fluorescence resonance energy transfer (smFRET), we demonstrate the temporal order of events in the trajectory of tRNA binding. Our results demonstrate that tRNA binds to the riboswitch in two steps, with its anticodon being recognized first, followed by NCCA binding accompanied with an inward motion of the 3' region of the T-box riboswitch, including Stem III and the anti-terminator stem, relative to Stem I. In addition, by introducing mutations at different locations of the T-box, we further show that the two-step binding kinetics is regulated by the modular structural elements in the T-box riboswitch.

Results {#s2}
=======

Binding of cognate tRNA by the *glyQS* T-box results in two distinct FRET states {#s2-1}
--------------------------------------------------------------------------------

To observe directly the binding of tRNA to the T-box, we placed the donor dye (Cy3) on the 3' end of a T-box fragment (T-box~182~), and the acceptor dye (Cy5) on the 5' end of the tRNA^Gly^, where the subscript '182' denotes the length of the T-box construct ([Figure 1A](#fig1){ref-type="fig"}). In vitro transcribed and labeled T-box and tRNA were purified and refolded according to published procedures ([@bib8]; [@bib47]) ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Labeling of the tRNA at the 5' end had a modest effect on the binding affinity ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). T-box~182~ spans Stem I, the linker sequence, Stem III and the anti-terminator, but does not contain the terminator sequence, thereby preventing the transition to the terminator conformation. A short RNA extension sequence was added to the 5' end of the T-box for surface immobilization ([Figure 2A](#fig2){ref-type="fig"}, [Supplementary file 1](#supp1){ref-type="supplementary-material"}). Single-molecule fluorescence images were recorded under equilibrium condition in the presence of 30 nM tRNA^Gly^-Cy5. Binding of tRNA^Gly^-Cy5 results in a major distribution of FRET values around 0.7, with 79 ± 4% of the traces showing a stable signal at 0.7 and 9 ± 5% traces sampling from 0.7 to 0.4 ([Figure 2B,C](#fig2){ref-type="fig"}). The SAXS model ([@bib8]) predicts a distance between the labeling positions at the 3' end of the T-box~182~ and the 5' end of the tRNA to be around 52 Å. ([Figure 1B](#fig1){ref-type="fig"}). Based on a Förster distance of 54--60 Å ([@bib23]; [@bib26]), our measured FRET value is within the range of estimated FRET values (0.56--0.70). Therefore, we assign the 0.7 FRET state to be the fully bound state of the tRNA^Gly^ by the T-box.

![Two-step binding of uncharged tRNA to the *glyQS* T-box riboswitch.\
(**A**) FRET labeling scheme for the T-box and tRNA. Cy3 (green star) and Cy5 (red star) fluorophores are attached at the 3' of the T-box (blue) and the 5' of the tRNA (black), respectively. *glyQS* T-box riboswitch molecules are anchored on slides through a biotinylated DNA probe (purple) hybridized to a 5' extension sequence on the T-box. (**B**) smFRET *vs.* time trajectories of T-box~182~-Cy3(3') with tRNA^Gly^-Cy5, T-box~182~-Cy3(3') with tRNA^ΔNCCA^-Cy5 and T-box~149~-Cy3(3') with tRNA^Gly^-Cy5. Cy3 and Cy5 fluorescence intensity traces (upper panel), and their corresponding smFRET traces calculated as I~Cy5~ / (I~Cy3+~I~Cy5~) (lower panel). (**C**) One-dimensional FRET histograms. FRET peaks are fit with a Gaussian distribution (black curve) and the peak centers are shown in red. 'N' denotes the total number of traces in each histogram from three independent experiments. (**D**) Transition density plot (TDP). Contours are plotted from white (less than 15% of the maximum population) to red (more than 85% of the maximum population). TDPs are generated from all smFRET traces from three independent experiments. (**E**) Representative smFRET trajectories showing real-time binding of tRNA^Gly^-Cy5 to T-box~182~-Cy3(3') in a steady-state measurement. Traces showing transitions from the unbound state (0 FRET) to fully bound state (0.7 FRET) through the partially bound state (0.4 FRET) (left) and unbound state directly to fully bound state (right). (**F**) Surface contour plot of time-evolved FRET histogram of T-box~182~-Cy3(3') with tRNA^Gly^-Cy5 (top) and tRNA^ΔNCCA^-Cy5 (bottom). Contours are plotted from blue (less than 5% of the maximum population) to red (more than 75% of the maximum population). 'N' denotes the total number of traces in each histogram from three independent experiments, which are a subset of traces showing real-time binding events in the steady-state measurements. Total numbers of traces in steady-state measurements are indicated in (C). Traces that reach the 0.7 FRET state (cutoff \>0.55) are included in the plot for tRNA^Gly^-Cy5 to reveal better the transition from the 0.4 to the 0.7 FRET state. Time-evolved FRET histograms of all traces are shown in [Figure 2---figure supplement 4D](#fig2s4){ref-type="fig"} for comparison.\
10.7554/eLife.39518.014Figure 2---source data 1.Cy3 and Cy5 intensity traces from three repeats for T-box~182~-Cy3(3') and tRNA^Gly^-Cy5.Each two columns show intensities of the Cy3/Cy5 pair from the same molecule.\
10.7554/eLife.39518.015Figure 2---source data 2.Cy3 and Cy5 intensity traces from three repeats for T-box~182~-Cy3(3') and tRNA^ΔNCCA^-Cy5.\
10.7554/eLife.39518.016Figure 2---source data 3.Cy3 and Cy5 intensity traces from three repeats for T-box~149~-Cy3(3') and tRNA^Gly^-Cy5.](elife-39518-fig2){#fig2}

In order to assign the 0.4 FRET value to specific tRNA binding states, tRNA^Tyr^-Cy5 and tRNA^ΔNCCA^-Cy5 ('ΔNCCA' denotes a tRNA^Gly^ with a deleted 3' NCCA sequence) were flowed in the flow-chamber with pre-immobilized T-box~182~-Cy3(3') (3' denotes that the label was added at the 3' end). We did not observe any binding of tRNA^Tyr^-Cy5 ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), confirming that recognition of the anticodon by the specifier region is required for tRNA binding. In the presence of tRNA^ΔNCCA^-Cy5, we observed a fluctuating signal between 0.4 and 0 FRET ([Figure 2B,D](#fig2){ref-type="fig"}), with a mean lifetime of the 0.4 FRET state of 3.6 ± 0.6 s and a mean waiting time before binding of 31.3 ± 5.3 s ([Figure 2---figure supplement 2B](#fig2s2){ref-type="fig"}). Taken together with the results from the tRNA^Gly^, tRNA^ΔNCCA^ and tRNA^Tyr^ binding experiments, we assign the 0.4 FRET state to a partially bound state where only the anticodon interactions have been established.

To further confirm the assignment of the FRET states, we generated T-box~149~, where the anti-terminator sequence is truncated ([Figure 1A](#fig1){ref-type="fig"}, [Supplementary file 1](#supp1){ref-type="supplementary-material"}). Based on the structure model from the SAXS data ([@bib8]) we predicted that a Cy3 dye placed either at the end of Stem III (T-box~149~) or at the end of the anti-terminator stem (T-box~182~) are localized in close proximity in three dimensions, further confirmed by the distance measurement using smFRET ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). Therefore, we expect that if tRNA^Gly^-Cy5 can reach the same fully bound state in T-box~149~ as in T-box~182~, a high FRET state centered at 0.7 would be observed. However, using T-box~149~-Cy3(3') in combination with tRNA^Gly^-Cy5, we again observed transient binding of tRNA^Gly^ with a FRET value centered at \~0.4 with the same mean lifetime as observed with the T-box~182~-Cy3(3') and tRNA^ΔNCCA^-Cy5 combination ([Figure 2B--D](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2C](#fig2s2){ref-type="fig"}). Therefore these two complexes (T-box~182~ + tRNA^ΔNCCA^ and T-box~149~ + tRNA^Gly^) represent the same binding state of the tRNA, that is the state where binding of the anticodon to the specifier region has been established, but is unstable without the further interactions between the NCCA and the t-box region.

Collectively, our results suggest a two-step binding model involving the separate establishment of the interactions with the anticodon and the NCCA. The fact that tRNA^Tyr^, which has a mismatched anticodon, but contains an intact NCCA 3' end, does not show any binding activity suggests that interactions with the anticodon precede the interactions with the NCCA end of the tRNA and are necessary for the establishment of the NCCA contacts. Without the interaction between the NCCA and the t-box sequence the binding of tRNA^Gly^ is not stable. From the binding kinetics of tRNA^ΔNCCA^, we estimated the association rate constant (*k*~1~) and the disassociation rate constant (*k~-~*~1~) for the first binding step to be (5.0 ± 1.6) x 10^5^ M^−1^s^−1^ and 0.28 ± 0.05 s^−1^, respectively (Figure 5; Figure 6E).

The transition from anticodon recognition to NCCA binding is rapid for uncharged tRNA {#s2-2}
-------------------------------------------------------------------------------------

We classified smFRET traces for T-box~182~-Cy3(3') in complex with tRNA^Gly^-Cy5 into three types ([Figure 2B](#fig2){ref-type="fig"}): (I) traces stably sampling the 0.7 state (79 ± 4% of total traces), (II) traces transiently transitioning from the 0.7 state to the 0.4 state (9 ± 5%), and (III) traces only sampling the 0.4 state without reaching 0.7 state (12 ± 5%). The low percentage of Type III traces indicates that once the anticodon is recognized, the commitment to the next binding step, NCCA interactions, is high. The majority of the traces showed that the tRNA^Gly^ remained mostly in the fully bound state (Type I) until the fluorophore photobleached, with the actual lifetime limited by photobleaching (τ~0.7~ \> 24 s, where τ~0.7~ denotes the lifetime of the 0.7 FRET state) ([Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}). The observation that tRNA^Gly^ is able to transit from the fully bound state back to the partially bound state (Type II) suggests that the NCCA/t-box interaction can break occasionally ([Figure 2B](#fig2){ref-type="fig"}). We estimated the lifetime of the transiently sampled partially bound state to be 0.35 ± 0.09 s in the presence of full-length tRNA^Gly^ ([Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}), \~10 fold shorter than the partially bound state in the presence of tRNA^ΔNCCA^.

While the majority of the T-box molecules were already bound to tRNA^Gly^ before starting data acquisition, we could detect that some molecules show real-time binding during imaging acquisition. We observed only a few traces briefly sampling the 0.4 FRET state from the zero FRET (unbound) state before reaching the 0.7 FRET state, while most traces directly sampled the 0.7 FRET state without a detectable 0.4 FRET, likely due to our imaging time resolution (100 ms per frame). We post-synchronized the FRET traces at the transition point from the zero FRET state to the first sampled 0.4 FRET state, and plotted them in a time-evolved FRET histogram. From the time-evolved FRET histogram ([Figure 2F](#fig2){ref-type="fig"}), we estimated roughly that the upper limit of the lifetime spent at the 0.4 FRET state is \~100 ms, very rapidly followed by establishment of NCCA/t-box interactions. In contrast, tRNA^ΔNCCA^ could not pass the 0.4 FRET state. To capture better real-time binding, we performed a flow experiment, where tRNA^Gly^-Cy5 was flowed into a chamber with immobilized T-box~182~-Cy3(3') during imaging acquisition. The corresponding post-synchronized time-evolved FRET histogram again shows a fast transition into the fully bound state ([Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}). In addition, the association rate constant of tRNA^Gly^ in the real-time flow experiment is (7.5 ± 0.7) x 10^5^ M^−1^s^−1^, consistent with the *k*~1~ of tRNA^ΔNCCA^ and confirming that the NCCA end of the tRNA does not participate in the first binding step.

From the real-time binding kinetics of tRNA^Gly^ to T-box~182~, we estimated a transition rate constant from the partially bound state to the fully bound state (*k*~2~) to be on the order of 10 s^−1^ ([Figure 2F](#fig2){ref-type="fig"}, [Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}). On the other hand, as transitions back to the partially bound state from the fully bound state were only observed in \~10% traces, we interpreted this to mean that the reverse transition rate constant (*k*~-2~) is very small, and the second binding step in the wild-type (WT) T-box with uncharged tRNA^Gly^ is close to irreversible (Figure 5; Figure 6E and see Discussion).

Establishment of the NCCA/t-box interaction is accompanied by conformational changes in the T-box riboswitch {#s2-3}
------------------------------------------------------------------------------------------------------------

We next investigated whether tRNA binding requires any conformational changes in the T-box itself. Using doubly labeled T-box~182~, with Cy3 at the 3' end and Cy5 at the 5' hybridization extension, we observed a high FRET state (centered at \~0.75) in the absence of tRNA ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Based on the structural model ([@bib8]), we estimated the distance between the 5' and 3' ends of the T-box~182~ to be \~36 Å ([Figure 1B](#fig1){ref-type="fig"}). Our measured FRET value is slightly less than the predicted FRET value (\~0.90), likely due to the engineered 5' extension sequence used to immobilize the T-box. No noticeable change was detected upon incubation with unlabeled tRNA^Gly^ ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), indicating that the 3' portion (Stem III plus the anti-terminator stem) does not move away from the 5' portion (Stem I). Given that the measured FRET efficiency of 0.75 is already located beyond the FRET sensitive region, it is unlikely that any inward motion of the 3' portion relative to the 5' could be detected. To overcome this limitation, we added extensions at both the 3' and 5' ends ([Figure 3A](#fig3){ref-type="fig"}, [Supplementary file 1](#supp1){ref-type="supplementary-material"}). ITC experiments suggest that addition of a 5' and/or a 3' extension sequences to the T-box does not affect tRNA binding ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). With this intra-T-box FRET scheme, we observed a FRET shift from \~0.5 to\~0.65 when tRNA^Gly^ was added ([Figure 3B](#fig3){ref-type="fig"}), indicating that the 3' half of the T-box moves closer to the 5' half, potentially with the T-box becoming more compact due to the presence of the cognate tRNA^Gly^. Adding non-cognate tRNA^Phe^ or tRNA^ΔNCCA^ gave similar FRET values as the T-box alone ([Figure 3B](#fig3){ref-type="fig"}), suggesting that the conformational change is associated with binding of both the anticodon and NCCA, not with anticodon recognition alone (Figure 5).

![Conformational changes following tRNA binding in the *glyQS* T-box riboswitch revealed by an intra-T-box FRET pair.\
(**A**) Intra-T-box FRET scheme. Cy3 (green star) and Cy5 (red star) are attached at the 5' and 3' extensions of T-box (blue), respectively. (**B**) One-dimensional FRET histograms of T-box~182~ alone, with tRNA^Phe^, with tRNA^ΔNCCA^, and with tRNA^Gly^. 'N' denotes the total number of traces in each histogram from three independent experiments.\
10.7554/eLife.39518.020Figure 3---source data 1.Cy3 and Cy5 intensity traces from three repeats for intra T-box~182~ FRET with 3' extension without tRNA.\
10.7554/eLife.39518.021Figure 3---source data 2.Cy3 and Cy5 intensity traces from three repeats for intra T-box~182~ FRET with 3' extension in the presence of tRNA^Phe^.\
10.7554/eLife.39518.022Figure 3---source data 3.Cy3 and Cy5 intensity traces from three repeats for intra T-box~182~ FRET with 3' extension in the presence of tRNA^ΔNCCA^.\
10.7554/eLife.39518.023Figure 3---source data 4.Cy3 and Cy5 intensity traces from three repeats for intra T-box~182~ FRET with 3' extension in the presence of tRNA^Gly^.](elife-39518-fig3){#fig3}

The NCCA end of the uncharged tRNA maintains its relative position to the K-turn region during the second binding step {#s2-4}
----------------------------------------------------------------------------------------------------------------------

Using the above two FRET pairs, we observed that the 3' portion of the T-box moves towards the base of Stem I as well as the NCCA end of the tRNA during the second binding step. To ascertain whether the NCCA end of the tRNA also moves relative to the base of Stem I, we measured FRET between a Cy3 placed at the 5' end of the T-box (T-box~182~-Cy3(5')) and tRNA^Gly^-Cy5 ([Figure 4A](#fig4){ref-type="fig"}). Using this FRET pair, binding of both tRNA^Gly^ and tRNA^ΔNCCA^ generated a similar FRET value centered at \~0.35 ([Figure 4B,C](#fig4){ref-type="fig"}). However, the FRET traces behaved differently for these two tRNA molecules. For tRNA^ΔNCCA^, the signal fluctuated between zero and 0.35 ([Figure 4D](#fig4){ref-type="fig"}), with a lifetime of the 0.35 FRET state of 4.5 ± 1.0 s, reminiscent of the 0.4 FRET state using the tRNA/T-box~182~-Cy3(3') FRET pair ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). For tRNA^Gly^, the signal was more stably centered at 0.35 ([Figure 4B](#fig4){ref-type="fig"}). Since the tRNA-Cy5/T-box~182~--Cy3(5') FRET pair cannot distinguish the partially bound from the fully bound state, we fit the lifetime with a double-exponential decay. The fast dissociation fraction has a lifetime of 3.9 ± 0.7 s (46 ± 21% of population), consistent with the lifetime for the partially bound state, and the low dissociation fraction has a lifetime of 15.7 ± 0.8 s (54 ± 21%), representing the stable fully bound state ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Overall, the measurements with the tRNA-Cy5/T-box--Cy3(5') FRET pair further validate the two-step binding model and reveal that the NCCA end of the uncharged tRNA maintains its relative position to the base of Stem I during the second binding step.

![FRET between fluorophores at the 5' end of the *glyQS* T-box riboswitch and 5' end of tRNA^Gly^ is insensitive to the two binding states.\
(**A**) Cy3 (green star) and Cy5 (red star) are attached at the 5' extension of the T-box (blue) and the 5' of the tRNA (black), respectively. (**B**) smFRET trajectories of T-box-Cy3(5') with tRNA^ΔNCCA^-Cy5 (left) and tRNA^Gly^-Cy5 (right). 'N' denotes the total number of traces in each histogram from three independent experiments. (**C**) One-dimensional FRET histograms of T-box-Cy3(5') with tRNA^ΔNCCA^-Cy5 (left) and tRNA^Gly^-Cy5 (right). (**D**) TDP of T-box-Cy3(5') with tRNA^ΔNCCA^-Cy5 (left) and tRNA^Gly^-Cy5 (right). Contours are plotted in the same way as in **[Figure 2D](#fig2){ref-type="fig"}.** TDPs are generated from all smFRET traces from three independent experiments.\
10.7554/eLife.39518.026Figure 4---source data 1.Cy3 and Cy5 intensity traces from three repeats for T-box~182~-Cy3(5') with tRNA^Gly^-Cy5.\
10.7554/eLife.39518.027Figure 4---source data 2.Cy3 and Cy5 intensity traces from three repeats for T-box~182~-Cy3(5') with tRNA^ΔNCCA^-Cy5.](elife-39518-fig4){#fig4}

A mutation in the T-loop region affects the first binding step but has minimal effect on the second binding step {#s2-5}
----------------------------------------------------------------------------------------------------------------

The interdigitated T-loops structure formed by the interactions between the distal bulge and the apical loop at the distal end of Stem I has been shown to be important for tRNA binding ([@bib17]; [@bib30]; [@bib47]). Specifically, C56 of the T-box stacks on a nucleobase in the D-loop of the tRNA, and a point mutation of C56 to U has been shown to reduce the tRNA binding affinity by \~40 fold ([@bib47]). We introduced the same mutation in the T-box~182~ backbone (T-box~C56U~) ([Figure 6A](#fig6){ref-type="fig"}, [Supplementary file 1](#supp1){ref-type="supplementary-material"}). The smFRET trajectories for tRNA^Gly^ binding to T-box~C56U~ are overall similar to the trajectories for WT T-box~182~, with a majority of traces (73 ± 6% of total traces) showing stable binding at 0.7 FRET state, and 13 ± 4% of the traces showing transitions back to the 0.4 FRET state ([Figure 6C,D](#fig6){ref-type="fig"}). τ~0.7~ was estimated to be at least \~23 s (limited by the photobleaching of the fluorophore) ([Figure 6E](#fig6){ref-type="fig"}). Post-synchronized time-evolved histogram on the subset of traces that demonstrated real-time binding shows fast transition to the fully bound state ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Comparison of tRNA^Gly^ binding to T-box~C56U~ and T-box~182~ suggest that the C56U mutation does not affect the second binding step. To investigate whether the mutation at the T-loop region affects the first binding step, we analyzed the binding and dissociation of tRNA^ΔNCCA^-Cy5 to T-box~C56U~-Cy3(3'). We found that the *k*~1~ of tRNA binding to T-box~C56U~ was roughly 20-fold slower compared to tRNA binding to T-box~182~, and the dissociation was roughly 2.5-fold faster compared to T-box~182~ ([Figure 6E](#fig6){ref-type="fig"}), leading to a \~ 50 fold higher dissociation constant for the first binding step. Our results suggest that the T-loop region of the T-box is critical during the first binding step, potentially aiding in anticodon recognition, but does not contribute significantly to the second binding step.

![Kinetic model for the two-step binding of *glyQS* T-box riboswitch and uncharged tRNA^Gly^.\
Details of the model are described in the text. Rate constants are summarized in [Figure 6E](#fig6){ref-type="fig"}.](elife-39518-fig5){#fig5}

![Regulation of the tRNA^Gly^ binding kinetics by structural elements in the *glyQS* T-box riboswitch.\
(**A**) Schematic diagram of three different mutations introduced to the T-box~182~ backbone (T-box~C56U~, T-box~SIII-Δ4bp~ and T-box~ΔKT~). (**B**) Representative smFRET traces of T-box~ΔKT~-Cy3(3') and tRNA^Gly^-Cy5. (**C**) FRET histograms of the T-box mutants with tRNA^Gly^-Cy5. 'N' denotes the total number of traces in each histogram from three independent experiments. (**D**) TDP of the T-box mutants with tRNA^Gly^-Cy5. TDPs are generated from all smFRET traces from three independent experiments and are plotted in the same way as in **[Figure 2D](#fig2){ref-type="fig"}. (E)** Table of kinetic parameters for tRNA^Gly^-Cy5 binding to different T-box constructs. *k~-1~*, *k~2~*, and *k~-2~* of T-box~ΔKT~-Cy3(3') are apparent rate constants estimated to allow comparison as described in Materials and methods. All rate constants are reported as mean ± standard deviation (S.D.) from three or four independent experiments.\
10.7554/eLife.39518.035Figure 6---source data 1.Cy3 and Cy5 intensity traces from three repeats for T-box~C56U~-Cy3(3') with tRNA^Gly^-Cy5.\
10.7554/eLife.39518.036Figure 6---source data 2.Cy3 and Cy5 intensity traces from four repeats for T-box~SIII-Δ4bp~-Cy3(3') with tRNA^Gly^-Cy5.\
10.7554/eLife.39518.037Figure 6---source data 3.Cy3 and Cy5 intensity traces from three repeats for T-box~ΔKT~-Cy3(3') with tRNA^Gly^-Cy5.\
10.7554/eLife.39518.038Figure 6---source data 4.Cy3 and Cy5 intensity traces from three repeats for T-box~C56U~-Cy3(3') with tRNA^ΔNCCA^-Cy5.\
10.7554/eLife.39518.039Figure 6---source data 5.Cy3 and Cy5 intensity traces from three repeats for T-box~SIII-Δ4bp~-Cy3(3') with tRNA^ΔNCCA^-Cy5.\
10.7554/eLife.39518.040Figure 6---source data 6.Cy3 and Cy5 intensity traces from three repeats for T-box~ΔKT~-Cy3(3') with tRNA^ΔNCCA^-Cy5.](elife-39518-fig6){#fig6}

A truncation of stem III has a minor effect on tRNA binding {#s2-6}
-----------------------------------------------------------

The functional role of Stem III is unclear. It has been speculated that Stem III might serve as a transcription stalling site to allow co-transcriptional folding and regulation of the T-box riboswitch ([@bib21]; [@bib50]). In addition, a SAXS data-derived model suggested coaxial stacking of Stem III and the anti-terminator stem, leading to a plausible role of Stem III in stabilizing the anti-terminator conformation in the presence of uncharged tRNA^Gly^ ([@bib8]). To investigate the latter hypothesis, we generated a T-box mutant (T-box~SIII-Δ4bp~), in which four base pairs in Stem III are deleted to significantly shorten its length ([Figure 6A](#fig6){ref-type="fig"}, [Supplementary file 1](#supp1){ref-type="supplementary-material"}). smFRET studies using T-box~SIII-Δ4bp~-Cy3(3') with tRNA^ΔNCCA^-Cy5 and tRNA^Gly^-Cy5 revealed insignificant difference in overall kinetics in the first and second step bindings ([Figure 6C--E](#fig6){ref-type="fig"}, [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). Noticeably, the τ~0.7~ was around 50% shorter than that for the T-box~182~ ([Figure 6E](#fig6){ref-type="fig"}), indicating that Stem III may contribute to the stabilization of the fully bound state, potentially through coaxial stacking with the anti-terminator stem, but the effect is minor.

A K-turn mutation affects both binding steps {#s2-7}
--------------------------------------------

We next investigated the role of the K-turn in regulating tRNA binding kinetics. We disrupted the K-turn (T-box~ΔKT~) by changing the six bulged nucleotides to three nucleotides (UCA) to replace the K-turn with a three base pair stem ([Figure 6A](#fig6){ref-type="fig"}, [Supplementary file 1](#supp1){ref-type="supplementary-material"}). In contrast to binding of tRNA^Gly^ to T-box~182~, binding to T-box~ΔKT~ results in three FRET states centered on \~0.2, 0.4, and 0.7. ([Figure 6B](#fig6){ref-type="fig"}). While the exact boundary of each FRET state is difficult to determine accurately from the FRET histogram ([Figure 6C](#fig6){ref-type="fig"}), a transition density plot (TDP) clearly reveals interconversion between the 0.2, 0.4, and 0.7 states ([Figure 6D](#fig6){ref-type="fig"}), with transitions between the 0.2 and 0.4 FRET states, and between the 0.4 and 0.7 FRET states more populated. Binding of tRNA^ΔNCCA^-Cy5 to T-box~ΔKT~, on the other hand, leads to the loss of population of the 0.7 state; however, both the 0.2 and 0.4 FRET states and fluctuations between these two states are frequently sampled ([Figure 6---figure supplement 3A,B](#fig6s3){ref-type="fig"}).

Comparing the tRNA^Gly^ and tRNA^ΔNCCA^ binding, we speculate that both the 0.2 and 0.4 FRET states observed in the case of the T-box~ΔKT~ represent the partially bound state in which only the anticodon and elbow are recognized. In contrast to T-box~182~, T-box~ΔKT~, with the K-turn replaced by an extension of Stem I, could potentially favor a relaxed conformation of Stem I, as observed in the NMR structure of an isolated K-turn and specifier loop domain ([@bib44]), generating a lower FRET value centered at 0.2. However, the sampling of the 0.4 FRET state in the T-box~ΔKT~ construct suggests that the interactions between the specifier and anticodon of the tRNA may transiently force open the extended base pair region and bend the T-box to adopt a similar conformation to the one observed in T-box~182~. The lifetimes of the 0.4 state before transition back to the 0.2 state and before transition forward to the 0.7 state are 0.30 ± 0.03 s and 0.13 ± 0.05 s, respectively ([Figure 6---figure supplement 3C](#fig6s3){ref-type="fig"}), indicating that this forced bent state is energetically unfavorable. However, this 0.4 FRET state is very likely to be required for the NCCA/t-box interaction to occur, as in the presence of tRNA^Gly^ the transitions from the 0.2 FRET to the 0.7 FRET state often pass through the 0.4 FRET state ([Figure 6B](#fig6){ref-type="fig"}). Furthermore, we observed a small region in the TDP corresponding to direct transitions between the 0.2 and 0.7 states. Given the very short lifetime of the 0.4 state, which is close to the time resolution of our experiments, the 0.2 to 0.7 state transition is likely to represent populations whose 0.4 FRET state lifetime is even shorter than the time resolution of the experiment.

The 3-step kinetic scheme for tRNA binding to T-box~ΔKT~ is presented in [Figure 6---figure supplement 3C](#fig6s3){ref-type="fig"}. The association rate constant *k*~1~ ((5.4 ± 2.9) x10^4^ M^−1^s^−1^), estimated from binding of tRNA^ΔNCCA^ to the T-box~ΔKT~, is \~9 fold smaller than binding to T-box~182~, suggesting that disruption of the K-turn affects anticodon recognition. Considering both the 0.2 and 0.4 FRET state as the partially bound state in T-box~ΔKT~, the apparent dissociation rate from the partially bound state *k~-~*~1_app~ of tRNA^ΔNCCA^ to T-box~ΔKT~ is 0.21 ± 0.06 s^−1^, similar to that for T-box~182~, suggesting that disruption of the K-turn does not affect the stability of the partially bound state. The 0.7 FRET state observed for T-box~ΔKT~ in the presence of tRNA^Gly^ is consistent with the FRET value for the fully bound state in the WT T-box, indicating that the NCCA/t-box interactions in T-box~ΔKT~ can still be formed. However, tRNA^Gly^ bound to T-box~ΔKT~ (τ~0.7~ = 1.6±0.3 s) is at least 15-fold less stable compared to tRNA^Gly^ bound to T-box~182~ (τ~0.7~ \>24 s). Furthermore, in contrast to the signal observed for tRNA^Gly^ binding to T-box~182~, in which fewer than 10% of the FRET traces show transitions back to 0.4 FRET, in T-box~ΔKT~ the vast majority of the traces show backward transitions to the 0.4 and 0.2 FRET states, contributing largely to the instability of the fully bound state. Based on the transition rates between 0.2, 0.4, and 0.7, we estimated the apparent forward (*k*~2_app~) and reverse (*k*~-2_app~) transition rates between the partially bound and the fully bound state of the T-box~ΔKT~ to be 1.3 ± 0.3 s^−1^ and 1.0 ± 0.3 s^−1^, respectively ([Figure 6E](#fig6){ref-type="fig"}, [Figure 6---figure supplement 3C](#fig6s3){ref-type="fig"}). The dramatically reduced *k*~2_app~ and increased *k*~-2_app~ in T-box~ΔKT~ leads to a \~ 150 fold change in the equilibrium constant in the second binding step compared to T-box~182~, implying that inflexibility of the K-turn region largely inhibits the conformational change in the T-box required to form the NCCA/t-box interaction, and strongly destabilizes the fully bound state.

Discussion {#s3}
==========

T-box riboswitches represent a unique class of riboswitches as they recognize a macromolecule and require interactions at multiple spatially separated sites on the ligand, unlike other riboswitches that respond to the binding of small ligands. Previous structural studies suggested that tRNA recognition by a T-box riboswitch is a bipartite process ([@bib18]; [@bib47]) with Stem I largely responsible for discriminating non-cognate tRNAs while the t-box sequence in the expression platform senses the charged state of the tRNA. We used smFRET to elucidate the binding kinetics of tRNA^Gly^ by the *glyQS* T-box riboswitch. With three FRET pairs between different T-box riboswitch and tRNA ligand constructs, our data collectively reveal a two-step model of uncharged tRNA^Gly^ binding to the *glyQS* T-box riboswitch ([Figure 5](#fig5){ref-type="fig"}). The first binding step involves recognition of the anticodon of the tRNA by the specifier sequence located in Stem I of the T-box riboswitch, leading to a partially bound state. In the second step, the 3' end of the T-box docks into the NCCA end of the tRNA through interactions with the t-box sequence, which leads to a fully bound state. Without the NCCA interaction, the binding of tRNA is unstable, with a mean lifetime of \~4 s, whereas with interactions both with the anticodon and the NCCA end, the binding of tRNA is very stable, with a mean lifetime \>24 s. It should be noted that the latter lifetime is likely to be much longer for two reasons: first, the measurement is limited by fluorophore photobleaching, i.e. the loss of signal is more likely to be due to photobleaching rather than the actual tRNA dissociation; second, the Cy5 label placed at the 5' end of the tRNA reduces the overall binding affinity by \~4 fold ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}), likely because the fluorophore impairs the NCCA/t-box interactions to some extent. In addition, an intra-T-box FRET pair at the 5' and 3' ends of the T-box demonstrates that, while the T-box is largely pre-organized in a folded state before tRNA binding, it still exhibits conformational rearrangement in a tRNA-dependent manner. Specifically, the 3' half of the T-box (including Stem III and the anti-terminator) moves inward relative to the 5' half (Stem I) of the T-box to accommodate the interaction with the NCCA end in the second binding step.

While our manuscript was in preparation, Suddala *et al.* ([@bib42]) reported a related single-molecule study on tRNA binding to the *glyQS* T-box riboswitch and proposed a similar two-step binding model. By using colocalized signals from the bound tRNA and the immobilized T-box, Suddala *et al.* ([@bib42]) uncovered two binding states distinguished by different dissociation rates of the tRNA, aided by using a Stem I-only mutant that cannot interact with the NCCA end of the tRNA. Specifically, in the model of Suddala *et al.* ([@bib42]) binding of the anticodon of the uncharged tRNA results in a relatively unstable state (with a lifetime of \~4--5 s), consistent with the partially bound state in our model, while binding both the anticodon and the NCCA end of the tRNA results in a stable state, consistent with the fully bound state in our model. Although both studies propose consistent kinetic models, in the study by Suddala *et al.* ([@bib42]), the FRET pair dyes are attached at the variable loop of the tRNA and the 3' or 5' end of the *glyQS* T-box, and do not generate different FRET signals to distinguish the partially bound state from the fully bound state. Therefore neither transitions between the partially bound and the fully bound states, nor the order of events during tRNA binding can be resolved in the study ([@bib42]). In contrast, by employing a FRET pair located at the 5' end of the tRNA and the 3' end of the *glyQS* T-box, we observed directly two FRET states corresponding to the recognition of the anticodon (0.4 FRET) and the binding of the NCCA (0.7 FRET), therefore our study allows the discrimination between different states and generates a more complete kinetic framework describing the full trajectory of the tRNA binding process. Our data reveal that anticodon recognition precedes the NCCA end interactions, and that after anticodon recognition the commitment to further establishment of the NCCA/t-box interaction is high. The T-box/tRNA^Gly^ complex transits rapidly from the partially bound state to the fully bound state, with a rate constant (*k*~2~) on the order of 10 s^−1^. Interestingly, our data also reveal that in the fully bound state the NCCA/t-box interaction is not highly-stable or ultra-stable. Brief disruption of the NCCA/t-box interactions can occur, but transition back to the fully bound state is rapid,\~10 fold faster than dissociation of the tRNA from the partially bound state. Therefore tRNA can remain bound during the breaking and reforming of the NCCA/t-box interaction. However, such transient breaking of NCCA/t-box interaction was only observed in \~10% of the total population, suggesting that the reverse transition rate constant (*k*~-2~) is overall very small.

Two-step binding mechanisms have been observed in a variety of protein or nucleic acid mediated biological process, including T-cell receptor (TCR) recognition of the major histocompatibility complex (MHC) presenting peptides, where TCRs scan the MHC scaffold first, followed by sensing of specific MHC-presenting peptides ([@bib46]); interaction of the signal recognition particle (SRP) receptor with the membrane, where SRP receptors interact with the membrane in a dynamic mode followed by an SRP-induced conformational transition into a stable binding mode ([@bib27]), DNA interrogation by CRISPR Cas9-crRNA, where Cas9-crRNA recognizes the protospacer adjacent motif (PAM) on the target DNA followed by sensing of the spacer sequence and triggering R-loop formation ([@bib41]); and RNA-induced silencing complexes (RISCs) binding to their mRNA targets, where dynamic sampling of the 'sub-seed' region occurs before targeting stably across the full seed region ([@bib7]; [@bib25]; [@bib36]; [@bib37]). In all of these cases, a two-step binding mechanism provides a good balance between sensitivity and specificity. T-box riboswitches fold and function co-transcriptionally in the cell, and hence we propose that a two-step kinetic model is kinetically beneficial during co-transcriptional folding of the T-box and sensing of the tRNA ligand. First, considering that the intracellular concentration of tRNA is on the order of µM in bacteria ([@bib1]; [@bib9]; [@bib10]), the binding of the tRNA ligand to the T-box riboswitch is rate limited by the first step. Pausing at Stem III in the presence of NusG in vitro was estimated to last 30--60 s ([@bib21]). Assuming an in vivo concentration of tRNA \~1 μM, the apparent tRNA binding rate in the first step is \~0.5 s^−1^, which is sufficient for the uncharged tRNA to reach the partially bound state during the pausing. Second, bacterial RNA polymerase (RNAP) elongates at a rate of 40--50 nt/s ([@bib33]; [@bib43]), and the length between terminator and anti-terminator sequences is \~40 nts; therefore the decision between termination and anti-termination needs to be made within \~0.5--1 s. On the one hand, the relatively slow dissociation (*k*~-1~) from the partially bound state can ensure the tRNA ligand stays bound until the completion of the anti-terminator sequence. On the other hand, very rapid transition into the fully bound state (*k*~2~) helps secure the interaction between the NCCA end of the tRNA and the t-box sequence and trap the T-box in the anti-terminator conformation before completion of transcription of the terminator sequence, which is immediately downstream. Finally, the fully bound state has a lifetime of at least 24 s, allowing RNAP to elongate more than 1000 nts before the tRNA dissociates. Therefore, the second binding step in the WT T-box with uncharged tRNA^Gly^ is close to irreversible in such biological setting. It is worth mentioning that Suddala *et al.* ([@bib42]) revealed that the uncharged T-box/tRNA^Gly^ complex exists in two populations: a stable complex, with a tRNA dissociation rate of \~0.03 s^−1^, and an ultra-stable complex, with a tRNA dissociation rate \<2.4×10^−4^ s^−1^. Our estimation of the lifetime of the fully bound state was limited by the introduction of Cy5 to the 5' end of the tRNA and fluorophore photobleaching, and therefore our experiments cannot distinguish between the stable and ultra-stable complexes. Nevertheless, both potential configurations in the fully bound state are stable enough to allow transcription read-through.

Based on the known structures of Stem I in complex with tRNA^Gly^ ([@bib18]; [@bib47]), it was hypothesized that the intra-T-box conformational change is likely to involve the K-turn region, which sits at the junction between the 5' and 3' portions of the T-box. Our observation that the NCCA end of the uncharged tRNA moves towards the anti-terminator stem (revealed by the T-box~182~-Cy3(3') and tRNA^Gly^-Cy5 FRET), but maintains its relative position to the K-turn region (revealed by the T-box~182~-Cy3(5') and tRNA^Gly^-Cy5 FRET) during the second binding step is consistent with the role of the K-turn region as the hinge of the intra-T-box conformational change. In addition, such conformational changes mediated by the K-turn region are Mg^2+^ dependent, as suggested by Suddala *et al.* ([@bib42]). Importantly, our results hint at the critical role of the K-turn region in promoting the fast coordination between anticodon sensing and locking of the NCCA end. Crystal structures of the Stem I/tRNA complex ([@bib18]; [@bib47]) show that Stem I flexes around the K-turn region and that this flexing seems to be important to establish the interactions between the anticodon and specifier sequence. Using a mutant where the K-turn region is removed, our data show that in the absence of the K-turn motif both the first and second binding steps are affected, but with a much more dramatic effect on the second step. In this specific K-turn mutant, where the K-turn is replaced by an extended Stem I helix, the conformational change in the T-box that brings closer the 3' and 5' portions becomes highly energetically unfavorable, leading to a \~ 10 fold reduction in *k*~2~, and \~15 fold destabilization of the fully bound state. Our kinetic measurement of the K-turn mutant explains the in vivo loss-of-function K-turn mutants ([@bib45]), and emphasizes the importance of the flexing around the K-turn region and the associated conformational changes in the T-box itself in the overall recognition and binding process.

Our results with various T-box mutants demonstrate that the T-box structural elements involved in tRNA recognition can drive the two-step binding process in a modular fashion. For example, in the first binding step, interactions with Stem I involve both anticodon recognition and the contacts between the interdigitated T-loops in Stem I and the elbow region (D- and T-loops) of the tRNA ([@bib18]; [@bib47]). When introducing a point mutation that impairs the T-loops/elbow region interaction ([@bib47]), we observed a dramatic decrease in the association rate constant and a moderate increase in the dissociation rate constant, leading to an overall \~50 fold reduction on the binding affinity for the first step, however the second step is unaffected. This observation suggests that establishment of the T-loops/elbow interactions is an important part of the Stem I/tRNA recognition process in the first binding step, but does not play any role in NCCA recognition in the second binding step. Similarly, truncation of Stem III has a minor effect on the stability of the fully bound state, but with no influence on the first binding step. Finally, the K-turn region (discussed above), which links the 5' and 3' portions of the T-box, plays a key role in coordinating the two binding steps by providing structural flexibility. It is worth mentioning that the impact on the tRNA binding kinetics by mutations in the T-loops, the K-turn, and the Stem III are consistent with the sequence conservation and the in vivo impact on amino acid-mediated transcription read-through using tyrS T-box riboswitches as a model system ([@bib24]; [@bib35]; [@bib45]). Mutations in the highly conserved T-loop and K-turn region have a more dramatic influence on the tRNA binding kinetics, translating into a larger in vivo impact. While the less conserved Stem III contributes to the stabilization of the anti-terminator conformation in vitro, deletion of it does not appear to significantly impair the tRNA binding process in vitro. Potentially its major function is to create a pause site to coordinate with the co-transcriptional folding of the T-box ([@bib21]; [@bib50]).

In conclusion, our study provides a comprehensive kinetic framework for describing tRNA recognition by the T-box riboswitch. The two-step binding process is driven by the specific structural elements of the T-box, and is likely to be kinetically beneficial for efficient, co-transcriptional recognition of the cognate tRNA ligand. Specific T-box structural elements drive the two-step binding process in a modular fashion, that is the 5' and 3' portions of the T-box are responsible for the first and second binding steps, respectively, with the K-turn region coordinating the two binding steps by allowing structural flexibility, providing a guideline for synthetic biology design of RNA regulatory modules, as well as for the development of new antibiotics using critical T-box structural elements as potential targets. Finally, the *glyQS* T-box riboswitch represents one of the simplest members of this class of riboswitches. Other T-box riboswitches are larger and have additional structural elements and can even appear in tandem arrangements ([@bib22]). While the two-step binding kinetics may be common to all T-box riboswitches, it is likely that the process in other T-box riboswitches shows differences modulated by the additional structural elements.

Materials and methods {#s4}
=====================

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\      Designation                Source or reference        Identifiers                                                    Additional information
  or resource                                                                                                                                       
  ---------------------------- -------------------------- -------------------------- -------------------------------------------------------------- ------------------------
  Gene (*Bacillus subtilis*)   *glyQS* T-box riboswitch   PMID: 28531275                                                                            

  Gene (*Bacillus subtilis*)   tRNA-Gly                   PMID: 9023104              RRID:[SCR_008636](https://scicrunch.org/resolver/SCR_008636)   

  Strain, strain\              DH5α                       Thermo Fisher Scientific                                                                  Catalogue \# 18265017
  background (*E. coli*)                                                                                                                            

  Recombinant\                 pUC19 Vector               New England Biolabs                                                                       Catalogue \# N3041S
  DNA reagent                                                                                                                                       

  Peptide,\                    T7 RNA polymerase          PMID: 3684574                                                                             
  recombinant protein                                                                                                                               

  Peptide,\                    BsaI                       New England Biolabs                                                                       Catalgue \#: M0535S
  recombinant protein                                                                                                                               

  Peptide,\                    RppH                       New England Biolabs                                                                       Catalgue \#: M0356S
  recombinant protein                                                                                                                               

  Chemical\                    Cyanine5 NHS ester         Lumiprobe                                                                                 Catalogue \# 13020
  compound, drug                                                                                                                                    

  Chemical\                    Cyanine3 hydrazide         Lumiprobe                                                                                 Catalogue \# 13070
  compound, drug                                                                                                                                    

  Software, algorithm          Origin 5.0                 Microcal Origin            RRID:[SCR_002815](https://scicrunch.org/resolver/SCR_002815)   

  Software, algorithm          ImageJ                     ImageJ                     RRID:[SCR_003070](https://scicrunch.org/resolver/SCR_003070)   

  Software, algorithm          MATLAB                     MATLAB                     RRID:[SCR_001622](https://scicrunch.org/resolver/SCR_001622)   

  Software, algorithm          NIS-Elements               Nikon                      RRID:[SCR_014329](https://scicrunch.org/resolver/SCR_014329)   
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------

RNA purification and mutagenesis {#s4-1}
--------------------------------

RNA transcription was performed in vitro using His~6~-tagged T7 RNA polymerase using standard protocols ([@bib32]). Cloning, design of a bicistronic DNA template encoding the *B. subtilis glyQS* T-box riboswitch and its cognate tRNA^Gly^, and conditions for in vitro transcription were described before ([@bib8]). For the experiments, all the RNAs from the crude transcription reaction were purified on a 7.5% denaturing (8 M Urea) polyacrylamide gel. The RNAs of interest were located on the gel by UV shadowing, the bands were cut out, and the RNAs were eluted into 50 mM sodium acetate (pH 7.0) buffer containing 200 mM potassium chloride by overnight rocking at 4°C. The eluted RNAs were precipitated by adding 3 volumes of cold 100% ethanol and stored overnight at −20°C. The precipitated RNAs were pelleted by centrifugation for 15 min at 20,000 g. The RNA pellets were washed three times in cold 80% ethanol, dried in a Speedvac and re-suspended in water. The concentration was estimated by its absorbance at 260 nm and was kept frozen at −20°C for long term storage. All mutant constructs were made using a commercial site directed mutagenesis protocol ([@bib29]) (Quikchange, Stratagene) and the RNAs were produced and purified by using the same protocol described above. The sequence of all mutant T-box and tRNA constructs were confirmed by sequencing and validated by MFOLD ([@bib51]) to ensure that the secondary structural elements were not affected by the mutations.

Fluorescent labelling of the RNA {#s4-2}
--------------------------------

For smFRET experiments, end labelling of RNA molecules was performed by modifying standard labelling protocols ([@bib34]). For 3' end labelling, 50 µg of RNA in 50 µL of reaction volume was incubated with 0.1 M Na-periodate in 0.1 M Na-acetate buffer at pH 5.2 for 90 min in the dark. The reaction was quenched by adding 5 µL of 2.5 M KCl and incubating on ice for 10 min. The resultant insoluble KIO~4~ was removed by centrifugation at 20,000 g for 30 min and the supernatant was passed through a P6 column (Bio-Rad) to exchange the buffer to 0.1 M HEPES (pH 7.0), 40% DMSO. The RNA was incubated with Cy3 hydrazide (Lumiprobe) dye for 45 min with a final RNA/dye ratio of \~1:200. The RNA was then ethanol precipitated as described above. The precipitated RNA was pelleted by centrifugation for 15 min at 20,000 g, dried in a Speedvac and re-suspended in water. The final RNA solution was passed through a P6 column to remove any residual free dye.

5' end labelling of RNA was performed by N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) -- N-hydroxysuccinimide (NHS) coupling through activation of the 5' monophosphate of the RNA by EDC and imidazole ([@bib34]). To improve the overall labelling efficiency of this method, a modified approach was used in which the 5' triphosphate of 100 µg of RNA was converted to 5' monophosphate in 100 µL reaction volume by incubating it with 100 units of RNA 5\' Pyrophosphohydrolase (NEB) at 37°C for 1 hr. The enzyme was removed by phenol chloroform extraction and the supernatant was passed through a P6 column to exchange the buffer to 10 mM HEPES (pH 7.0), 150 mM NaCl, 10 mM EDTA. This was followed by addition of 12.5 mg of EDC to the RNA solution along with 50 µL of ethylene diamine and 200 µL of 0.1 M imidazole buffer (pH 6.0). The reaction was incubated for 3 hr at 37°C and the RNA was then ethanol precipitated as described above. The resultant RNA pellet was re-suspended in 0.1 M sodium carbonate buffer (pH 8.7) and residual EDC was removed by passing the solution through a P6 column. The resultant RNA solution in 0.1 M sodium carbonate buffer (pH 8.7) was incubated with Cy5 NHS (Lumiprobe) dye for 45 min with a final RNA/dye ratio of \~1:200. The RNA was ethanol precipitated as described above and re-suspended in water. The final RNA solution was passed through a P6 column to remove any residual free dye. The overall labelling efficiency of RNA constructs used in this study varied from 75% to 95%.

Isothermal titration calorimetry {#s4-3}
--------------------------------

The thermodynamic parameters associated with binding of tRNA^Gly^ to *glyQS* T-box were determined at 25°C by using an ITC-200 Micro-Calorimeter (MicroCal). Prior to the experiment, the two interacting RNAs (in 50 mM HEPES pH 7.0, 100 mM KCl) were refolded separately by first heating for 3 min at 90^o^ C followed by incubation on ice for 2 min. At this point, MgCl~2~ was added to attain a final concentration of either 1 mM or 10 mM. The RNA solution was then heated to 50^o^ C for 10 min and 37^o^ C for 30 min followed by cooling to 25°C. The refolded RNA was then concentrated using a 10 kDa cutoff Amicon filter and washed three times with the final ITC buffer (50 mM HEPES pH 7.0, 100 mM KCl and 10 mM MgCl~2~ or 1 mM MgCl~2~). For testing the binding of T-box with unlabeled and 5' Cy5 labelled tRNA in 10 mM MgCl~2~ buffer, the sample cell was filled with 6.6 µM and 11 µM T-box respectively and the corresponding concentration of tRNA^Gly^ in the syringe was 111 µM and 152 µM. For the ITC experiment in 1 mM MgCl~2~ buffer, the cell was filled with T-box at a concentration of 6.7 µM and the syringe concentration of unlabeled tRNA^Gly^ was 72 µM. For each ITC experiment, the titration was carried out by stepwise (2 µL) injection of tRNA^Gly^ from a stirred syringe (1000 rev/min) into the sample cell. Successive injections were spaced by 150 s and values for the change in enthalpy (ΔH~b~), association constant (K~b~), change in enthalpy (ΔH~b~) and stoichiometry (n) were determined by nonlinear least-squares fitting of the data using Origin 5.0 software (OriginLab).

Electrophoretic mobility shift assay {#s4-4}
------------------------------------

The T-box and tRNA were denatured and refolded using the same protocol as described for the ITC and smFRET experiments. For binding of tRNA, 5 µL of 4 µM of folded T-box and 5 µL of 2 µM folded tRNA samples were mixed together for 30 min in final buffer containing 50 mM HEPES pH 7.0, 100 mM KCl and 15 mM MgCl~2~. The folded T-box or T-box +tRNA mixture were loaded on to 6% native polyacrylamide gel containing 15 mM MgCl~2~ and the gel was run at room temperature for 2--2.5 hr. RNAs were stained by SYBR^TM^ green RNA staining dye (Invitrogen). The gel was imaged using ChemiDoc (Bio-rad) in SYBR green channel (for unlabeled T-box constructs), Cy5 channel (for tRNA-Cy5), or Cy3 channel (for labeled T-box constructs). Images were processed and analyzed by ImageJ ([@bib38]).

Fluorophore conjugation of DNA oligos {#s4-5}
-------------------------------------

DNA oligos that hybridize to 5' extension and 3' extension of the T-box construct were purchased from Integrated DNA Technologies with an amine modification at the 5' end and 3' end respectively. 13.5 µL of 100 µM DNA oligo was mixed with 1.5 µL of 1 M NaHCO~3~ (pH 8.6). 25 µg of NHS conjugated fluorophore (Cy3 or Cy5) was dissolved with 0.5 µL DMSO and mixed with the DNA oligo solution. The mixture was incubated at 37^°C^ overnight. 1.67 µL of 3 M NaOAc and 50 µL of pure ethanol was added to the mixture to precipitate the conjugated DNA oligo overnight at −20°C. The precipitated DNA oligo was pelleted by centrifugation for 30 min at 21000 g and re-suspended with 40 µL water. The DNA solution was passed through a P6 column to remove any residue free dye and salt. The overall fluorophore labeling efficiency is \~60%.

smFRET measurements {#s4-6}
-------------------

Slides containing microfluidic channels were prepared as previously described ([@bib3]). Slides and coverslips were coated with a mixture of poly-ethylene glycol (PEG, Mw = 500,000) and PEG-biotin (Mw = 500,000) according to previously published protocol ([@bib3]). The T-box and tRNA were denatured and refolded using the same protocol described for the ITC experiments with the final buffer containing 50 mM HEPES pH 7.0, 100 mM KCl, and 15 mM MgCl~2~. T-box RNA was hybridized to the biotinylated DNA oligo at the extension during refolding, and immobilized via biotin-streptavidin interactions to the surface. tRNA was diluted in imaging buffer (50 mM HEPES pH 7.0, 100 mM KCl, 15 mM MgCl~2~, 5 mM protocatechuic acid (PCA) (Sigma), 160 nM protocatechuate-3,4-dioxygenase (PCD) (Sigma), and 2 mM Trolox (Sigma)) and flowed into the microfluidic channels. smFRET measurements were performed with an objective based total internal reflection fluorescence (TIRF) microscope based on a Nikon Ti-E with 100X NA 1.49 CFI HP TIRF objective (Nikon). A 561 nm laser (Coherent Obis at a power density of 4.07 × 10^5^ W/cm^2^) was used for the FRET measurement. A 647 nm laser (Cobolt MLD at a power density of 5.88 × 10^5^ W/cm^2^) was used for direct excitation of Cy5 to check the presence of the acceptor. Emissions from both donor and acceptor were passed through an emission splitter (OptoSplit III, Cairn), and collected at different locations on an EMCCD (iXon Ultra 888, Andor). 1500 frames of time-lapse images were taken with 100 ms exposure time. Each independent measurement in our study should be considered as a technical replicate. The biological samples (i.e. the in vitro transcribed tRNAs and T-boxes) were generated once. In each measurement, T-box and tRNA were folded, smFRET images were recorded, and analysis were performed independently.

Lifetime analysis {#s4-7}
-----------------

Individual spots were picked from maximum intensity projection of Cy5 emission channel ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) using NIS Elements software, that is only the pixels with the highest intensity value of the same XY coordinates in time-lapse images are displayed in the maximum intensity projection image. Fluorescent intensity trajectories of these spots were generated from Cy3 and Cy5 channels of time-lapse images, and corrected for baseline and bleed-through in MATLAB as previously described ([@bib12]). FRET traces were generated by calculating I~Cy5~ / (I~Cy5~+I~Cy3~) at each time point from the intensity trajectories. smFRET traces were idealized by fitting with a Hidden Markov Model using vbFRET ([@bib5]). Dwell time of each FRET state before transition to another FRET state of individual traces was extracted from the idealized traces and the dwell time histograms were fit with exponential decay by Origin 7.0 (OriginLab) ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). In most of the cases, dwell time histograms fit well with a single exponential decay (A.exp(-t/t~0~) + y~0~). In a few cases, in which mixed populations with different lifetimes were expected, dwell time histograms were fit with a double exponential decay (A~1~.exp(-t/t~1~) + A~2~.exp(-t/t~2~) + y~0~) and the population-weighted average lifetime was calculated by (A~1~.t~1~ +A~2~.t~2~) / (A~1~ + A~2~). The latter cases are explicitly mentioned in the text.

Determination of kinetic parameters {#s4-8}
-----------------------------------

### (I) *k*~-1~ {#s4-8-1}

For all T-box constructs, *k*~-1~ was estimated from the dwell time of the partially bound state (0.4 FRET state of T-box~182~, T-box~C56U~ and T-box~SIII-**Δ**4bp~) of tRNA^ΔNCCA^-Cy5 ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). The dwell time of the partially bound state was fit with a single exponential decay. The lifetime of 0.4 FRET state (τ~0.4-0~) was extracted and k~-1~ was calculated using the following equation:$$k_{- 1} = \frac{1}{\tau_{0.4 - 0}}$$

### (II) *k*~1~ {#s4-8-2}

We noticed that the lifetime of the unbound state (τ~0-0.4~) of tRNA^ΔNCCA^-Cy5 with Tbox~182~-Cy3(3') was 31.3 ± 5.3 s, while the average smFRET trace length (τ~trace~) was 70 ± 7 s under 4.07 × 10^5^ W/cm^2^ 561 nm laser ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}), limited by Cy3 photobleaching. Therefore, there was a possibility of underestimating the lifetime of the unbound state, or overestimating *k*~1~. We hence characterized the photobleaching effect on unbound state lifetime analysis using reduced 561 nm laser power (1.96 × 10^5^ W/cm^2^). τ~0-0.4~ was calculated to be 46 ± 4 s and τ~trace~ was 103.0 ± 0.6 s. To correct for the photobleaching effect, we estimated *k*~1~, using the following equation ([@bib2]; [@bib13]):$$k_{1} = \left( {\frac{1}{\tau_{0 - 0.4}} - \frac{1}{\tau_{trace}}} \right) \times \frac{1}{\left\lbrack tRNA \right\rbrack}$$where \[tRNA\] represents the concentration of tRNA^ΔNCCA^-Cy5. *k*~1~ values were consistent using both high laser power ((5.8 ± 0.2) x 10^5^ M^−1^s^−1^) and low laser power ((4.1 ± 0.6) x 10^5^ M^−1^s^−1^). In [Figure 6E](#fig6){ref-type="fig"}, we reported the mean ±S.D. of *k*~1~ obtained with both high and low laser powers.

We also measured τ~off~ in the flow experiment and it was determined by the dwell time between the injection time and detection of the first binding event ([Figure 2---figure supplement 4C](#fig2s4){ref-type="fig"}). *k*~1~ calculated for tRNA^Gly^ in the flow experiment was consistent with the value for tRNA^ΔNCCA^ in the steady-state experiment. We therefore used k~1~ of tRNA^ΔNCCA^-Cy5 binding to the T-box to approximate the rate constant for the first binding step in all T-box constructs.

For some T-box mutants (specifically, T-box~C56U~-Cy3 and T-box~ΔKT~-Cy3), binding of tRNA-Cy5 became less efficient compared to the T-box~182~-Cy3(3'), already a hint of a deficient first binding step. In this case, estimation of *k*~1~ from the selected FRET traces will highly bias for the molecules that bind relatively fast within the photobleaching time of Cy3, therefore significantly overestimating *k*~1~. We therefore applied a different approach to estimate *k*~1~ for the T-box mutants. We counted trace percentage of the T-box mutants (number of FRET traces divided by the number of Cy3 spots) and normalized it to the trace percentage of T-box~182~ with tRNA^ΔNCCA^-Cy5 to get the normalized trace percentage (*f*) ([Figure 6---figure supplement 4](#fig6s4){ref-type="fig"}).

We performed Gillespie simulations ([@bib14]; [@bib15]; [@bib16]) on the observed signal as a function of *k*~1~ and *k*~-1~ during the first binding step. The simulated signal mimicked the experiment and imaging processing. As our FRET traces were selected from the maximum intensity projection of the acceptor signal ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) regardless of the lifetime of the bound state, as long as there was a binding event during the imaging time window (70 s considering the photobleaching time of the donor dye), it would generate a signal (as a 'footprint') that showed in the output image of maximum projection ([Figure 6---figure supplement 5A](#fig6s5){ref-type="fig"}). For each parameter set, 2000 binding trajectories were simulated, and the fraction of the molecules that generated signal in the maximum intensity projection (referred to as '*f*') within the 70 s time window was calculated. The simulation shows that *f* is insensitive to *k*~-1~, at least within the *k*~-1~ we observed for the various T-box constructs ([Figure 6---figure supplement 5B](#fig6s5){ref-type="fig"}), and that the dependence of *f* on *k*~1~ is best described as$$f = f_{0} - ae^{bk_{1}}$$where *f*~0~ is the binding fraction at saturation, and *a* and *b* are constants ([Figure 6---figure supplement 5B](#fig6s5){ref-type="fig"}). By fitting ln(*f*~0~-*f*) *vs. k*~1~ with a linear function ([Figure 6---figure supplement 5C](#fig6s5){ref-type="fig"}) we estimated *k*~1~ as$$k_{1} = \frac{0.45 - {\ln\left( {1.557 - f} \right)}}{72.09}$$

The standard deviations reported for *k*~1~ were calculated by an error propagation function considering the standard deviation of *f*.

### (III) *k*~2~ and *k*~-2~ {#s4-8-3}

Even though we observed that smFRET traces of tRNA^Gly^ with T-box~182~, T-box~C56U~ and T-box~SIII-Δ4bp~ exhibit real-time binding, the majority of the traces show single-step binding from unbound to fully bound state while only a few traces sample the partially unbound state within 0.1 s ([Figure 2F](#fig2){ref-type="fig"}, [Figure 2---figure supplement 4B](#fig2s4){ref-type="fig"},[Figure 6---figure supplements 1A](#fig6s1){ref-type="fig"} and [2A](#fig6s2){ref-type="fig"}). For this reason, our calculation of *k*~2~ is limited by the imaging time resolution and we estimate the transition from 0.4 to 0.7 is rapid with a *k*~2~ larger than 10 s^−1^.

We can also detect transition from 0.7 FRET to 0.4 FRET, and calculate the lifetime of 0.7 FRET to 0.4 FRET (τ~0.7-0.4~) ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). However, the fraction of traces showing this transition is small. Since most of the traces demonstrate long time 0.7 FRET, we reason that *k~-2~* should be very small and the second binding step for these three constructs is close to irreversible.

### (IV) Kinetic model for T-box~ΔKT~ {#s4-8-4}

The kinetic model for tRNA binding to the K-turn mutant T-box~ΔKT~ is illustrated in [Figure 6---figure supplement 3C](#fig6s3){ref-type="fig"}, with kinetic parameters marked. Specifically, the partially bound state contains a relaxed conformation and a bent conformation at the original K-turn region. The interconversion rates between 0.2, 0.4 and 0.7 FRET states were determined by the lifetime of the each FRET state before transitioning to the other FRET state. To compare better the kinetic parameters with other T-box constructs, we calculated the apparent *k*~2~ considering both pathways (0.2→0.7 and 0.2→0.4→0.7) ([Figure 6---figure supplement 3C](#fig6s3){ref-type="fig"}) as below:$$k_{2\_ app} = \left( {{p_{1}\frac{k_{1}^{'}k_{2}^{'}}{\left( k_{1}^{'} + k_{- 1}^{'} \right)} + p}_{2}k_{2}} \right)$$

Where *p*~1~ and *p*~2~ are the probabilities of the 0.2→0.4→0.7 and 0.2→0.7 pathways respectively. And we calculated the apparent *k~-~*~2~ considering both pathways (0.7→0.2 and 0.7→0.4) ([Figure 6---figure supplement 3C](#fig6s3){ref-type="fig"}) as shown below:$$k_{- 2\_ app} = \left( {{p_{1}k_{- 2}^{'} + p}_{2}k_{- 2}} \right)$$

Where *p*~1~ and *p*~2~ are the probabilities of the 0.7→0.4 and 0.7→0.2 pathways, respectively. To compare with the *k*~-1~ of other T-box constructs, the apparent *k*~-1_app~ of T-box~ΔKT~ was estimated by considering both 0.4 and 0.2 FRET states.
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###### Secondary structure diagram of the constructs used for the smFRET studies.

The diagrams show all the constructs used for the experiments. The 5' extensions added to attach the T-box constructs to the surface are shown in red. The Tbox~182~ construct was made with only a 5'extension and also with extensions at both the 5' and 3' ends (red).
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All data generated or analysed during this study are included in the manuscript and supporting files. smFRET trajectories of each data sets included in the manuscript are available in Source Data.
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Decision letter

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Specific structural elements of the T-box riboswitch drive the two-step binding of the tRNA ligand\" for consideration by *eLife*. Your article has been reviewed by Gisela Storz serving as both Reviewing and Senior Editor, a Reviewing Editor, and three reviewers. The following individuals involved in review of your submission have agreed to reveal their identity: Adrian Ferre-D\'Amare (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The manuscript by Zhang et al., describes the results of smFRET studies on the recognition of uncharged tRNA by the T-box riboswitch. These are widespread bacterial riboregulators that employ the charge state of tRNA as a proxy for the intracellular concentration of specific amino acids. Previous genetic, biochemical and structural studies have elucidated the nature of the RNA-RNA interactions that give rise to specific interactions between the T-box and a cognate tRNA. However, the kinetics of the association have remained largely unexplored. In this manuscript, the authors use smFRET to characterize the association of a model T-box with its cognate tRNA. By judicious combination of labeling schemes as well as mutant T-boxes, the authors derive a two-step binding model and provide, for the first time, a quantitative kinetic framework for the association of the two RNAs. The T-box-tRNA interaction is an outstanding model system to elucidate how two non-coding RNAs associate specifically, making this work not only of interest to those who study riboswitches, but to the larger community of scientists who study non-coding RNAs.

Essential revisions:

Overall, the manuscript is well written and easy to follow, and the interpretations are sound. The highlight of the study is the capture and mechanistic interpretation of the partially bound states, which reflects the strength of single molecule techniques.

1\) As the authors note, a superficially similar paper from the Nikonowicz and Walter labs analyzing T-box-tRNA association was published recently. However, the labeling scheme used by those authors precludes the analysis of T-box conformational accommodation. This is an important distinction, and the current study complements the recently published work from the Nikonowicz and Walter labs in important ways. However, the description of the work by Suddala et al., should be improved, Zhang et al., should discuss more clearly what insights they have obtained and how they extend and complement the experiments from the Nikonowicz and Walter labs. In particular, Suddala et al., carried out colocalization experiments, which are extremely powerful in detecting binding events that do not result in FRET. In addition, they observed Mg^2+^ dependence on the switching, providing additional evidence that the K-turn switch may be metal dependent. They also observed three different off rates (k^fast^, k^medium^, and k^slow^). It is unclear how these three rates relate to the two states proposed here. Finally, Suddala et al., provided data that EFTu does not affect binding kinetics, which should likely be cited in this paper.

2\) For broad interest to the bacterial gene regulation and riboswitch communities, the authors should expand on the in vivo consequences of the in vitro kinetics. Specifically:

\- The authors at their own discretion may consider referencing the biological consequences of the mutations that are studied using the single molecule approach (if that information is already available)? For example, what happens in bacteria as a result of K-turn mutation, mutation C56, or stem III truncation? If this information is already in hand, it could help tie together the kinetics results with in vivo consequences for riboswitch regulation.

\- The authors could provide a much more detailed link between their kinetic mechanism and the regulatory consequences given observed rates of transcription and pausing. The authors can potentially put numbers to many of these events. This has been done to some extent in the work by Suddala et al. It would be interesting to see how things change with the kinetics observed here.

\- In general, the authors may undersell the two-step mechanism a bit. In what types of other systems (e.g., Cas9? Ago?) have two step binding mechanisms been observed? Is this potentially a general strategy for promoting fidelity? Would incorporating a proofreading/fidelity step be useful for thinking about biotechnology applications?

3\) The labeling scheme employed in this work places a dye at the 5\'-terminus of tRNA. While qualitative, previous biochemical work (Zhang and Ferre-D\'Amare, (2014) suggested intimate coaxial stacking between the antiterminator element of the T-box and the acceptor stem of tRNA. Thus, an important control experiment is to show that placing a dye at the 5\'-terminus of tRNA does not impact tRNA-T-box association, or to determine what the effect is. An ITC experiment (like the one authors' report, for other purposes, in Figure 3---figure supplement 2) would be pretty clear in this regard.

4\) The experiment establishing the kink-turn as the hinge point for the conformational change between the partially bound and full complex is on the weak side. The authors claim that the absence of a FRET change in their experiment is evidence that the kink-turn must be the point where flexing occurs. An alternative interpretation of this experiment could be that this just shows that the tRNA is not changing position relative to the anchor point during this transition, rather than pinpointing to where the T-box is bending to form the full complex. An experiment that gives a positive result upon kink-turn bending and full complex formation would be stronger evidence for the claim that the kink-turn is the main source of conformational change.

5\) The authors conclude from their experiments that tRNA binding is a two-step process where the Stem-I interaction occurs first followed by the anti-terminator interaction. This is likely true in vivo where Stem-I emerges from the polymerase first. However, in their system the possibility exists that the anti-terminator interaction occurs first followed by Stem-I. Would the authors be able to discern FRET traces where this occurs using their set-up? Are transitions besides the.4 to.7 state observed? If the anti-terminator is never found to be bound first, can the authors provide a reason?

6\) Subsection "Binding of cognate tRNA by the glyQS T-box results in two distinct FRET states", it is unclear why some molecules are transitioning here, and others are not. In the recently published T-box paper from the Walter lab, Walter et al., stressed that their T-box was purified under native conditions. While in this work the RNA was denatured. How was the RNA refolded? Have the authors run a native gel of their RNA to detect possible folding heterogeneity that could explain some of these results?

7\) Subsection "Determination of kinetic parameters", can the authors provide additional information (or a reference or a simulation) for adjusting the fitted kinetic parameter based on the percentage of data observed? Does this really scale strictly as a percentage? How does the error in the fit scale?

10.7554/eLife.39518.045

Author response

> Essential revisions:
>
> Overall, the manuscript is well written and easy to follow, and the interpretations are sound. The highlight of the study is the capture and mechanistic interpretation of the partially bound states, which reflects the strength of single molecule techniques.

We are glad that the reviewers found that our manuscript is well written and easy to follow, the interpretations are sound, and the conclusions are of interest to the broader scientific community.

> 1\) As the authors note, a superficially similar paper from the Nikonowicz and Walter labs analyzing T-box-tRNA association was published recently. However, the labeling scheme used by those authors precludes the analysis of T-box conformational accommodation. This is an important distinction, and the current study complements the recently published work from the Nikonowicz and Walter labs in important ways. However, the description of the work by Suddala et al.,. should be improved, Zhang et al., should discuss more clearly what insights they have obtained and how they extend and complement the experiments from the Nikonowicz and Walter labs. In particular, Suddala et al., carried out colocalization experiments, which are extremely powerful in detecting binding events that do not result in FRET. In addition, they observed Mg^2+^ dependence on the switching, providing additional evidence that the K-turn switch may be metal dependent. They also observed three different off rates (k^fast^, k^medium^, and k^slow^). It is unclear how these three rates relate to the two states proposed here. Finally, Suddala et al., provided data that EFTu does not affect binding kinetics, which should likely be cited in this paper.

In the revised manuscript the comparison between our study and the study from the Nikonowicz and Walter laboratories is more extensive and complete. It emphasizes the experiments and conclusions in their study that are different from our studies. To a large extent, both studies are highly complementary and address non-overlapping aspects of T-box/tRNA binding kinetics. We made the following specific changes, as suggested by the reviewers, and included them in the Results section and Discussion section.

We now mention in the discussion that Suddala et al., used colocalized signals from the bound tRNA and the T-box to study the tRNA binding kinetics. While we did not use colocalization as a way to study tRNA binding, our choice of tRNA labeling positions makes the FRET value high enough (0.4 at least) to use the FRET signal reliably to report on binding. In fact, our k~on~ and k~off~ estimates from the partially bound state are highly consistent with the numbers reported by Suddala et al., providing further validation for using FRET signal to report binding.

We now mention the Mg-dependent conformational change reported by Suddala et al., when we discuss the K-turn mutant.

"In addition, such conformational changes mediated by the K-turn region are Mg^2+^ dependent, as suggested by Suddala et al. (Suddala et al., 2018)."

In addition, in Figure 1---figure supplement 2 we include ITC binding data done at 1mM MgCl2 concentration that shows clearly that tRNA binding at this Mg concentration is completely abolished. This shows that tRNA binding by the T-box is Mg dependent and the T-box is an Mg-dependent switch.

The lifetime of the fully bound state is consistent with the k~off~^medium^ in the study by Suddala et al. As we did not perform imaging with low time resolution (e.g. 20 s as in the work by Suddala et al.), we cannot fully distinguish k~off~^medium^ and k~off~^slow^ in our results. It is possible that the fully bound state contains two populations with tRNA dissociating with different rates. However, in our model the key conclusion is that the fully bound state is a relatively stable complex with a lifetime of at least 24 s, and probably longer, which is long enough to be functionally important as it allows transcription of the terminator sequence. We include the comparison of the lifetimes obtained in both studies in the Discussion section:

"By using colocalized signals from the bound tRNA and the immobilized T-box, Suddala et al. (Suddala et al., 2018) uncovered two binding states distinguished by different dissociation rates of the tRNA, aided by using a Stem I-only mutant that cannot interact with the NCCA end of the tRNA. Specifically, in the model of Suddala et al. (Suddala et al., 2018) binding of the anticodon of the uncharged tRNA results in a relatively unstable state (with a lifetime of \~4-5 s), consistent with the partially bound state in our model, while binding both the anticodon and the NCCA end of the tRNA results in a stable state, consistent with the fully bound state in our model."

and

"Finally, the fully bound state has a lifetime of at least 24 s, allowing RNAP to elongate more than 1,000 nts before the tRNA dissociates. Therefore, the second binding step in the WT T-box with uncharged tRNA^Gly^ is close to irreversible in such biological setting. \[...\] Nevertheless, both potential configurations in the fully bound state are stable enough to allow transcription read-through."

We have now cited the paper in the introduction when mentioned EF-Tu.

*2) For broad interest to the bacterial gene regulation and riboswitch communities, the authors should expand on the* in vivo *consequences of the* in vitro *kinetics. Specifically:*

*- The authors at their own discretion may consider referencing the biological consequences of the mutations that are studied using the single molecule approach (if that information is already available)? For example, what happens in bacteria as a result of K-turn mutation, mutation C56, or stem III truncation? If this information is already in hand, it could help tie together the kinetics results with* in vivo *consequences for riboswitch regulation.*

We now cite work from the Henkin laboratory on in vivo characterization of tyrS T-box riboswitches carrying mutations in the T-loop and the K-turn regions. While these in vivo studies are on a different T-box, these two regions are highly conserved, therefore it is possible to expect similar in vivo functional attenuation by glyQS T-box riboswitches carrying equivalent mutations. As we indicated previously in the manuscript, the Stem III mutant shows a minor impact on tRNA binding kinetics and hence we speculate that the in vivo relevance of Stem III is related to the promotion of transcriptional pausing during T-box co-transcriptional folding. Unlike the other two regions, Stem III is not highly conserved. We revised the manuscript as below:

"It is worth mentioning that the impact on the tRNA binding kinetics by mutations in the T-loops, the K-turn, and the Stem III are consistent with the sequence conservation and the in vivo impact on amino acid-mediated transcription read-through using tyrS T-box riboswitches as a model system (Henkin, 2014; Rollins et al., 1997; Winkler et al., 2001). Mutations in the highly conserved T-loop and K-turn region have a more dramatic influence on the tRNA binding kinetics, translating into large in vivo impact. While the less conserved Stem III contributes to the stabilization of the anti-terminator conformation in vitro, deletion of it does not appear to significantly impair the tRNA binding process in vitro. Potentially its major function is to create a pause site to coordinate with the co-transcriptional folding of the T-box (Grundy and Henkin, 2004; Zhang and Landick, 2016)."

> \- The authors could provide a much more detailed link between their kinetic mechanism and the regulatory consequences given observed rates of transcription and pausing. The authors can potentially put numbers to many of these events. This has been done to some extent in the work by Suddala et al. It would be interesting to see how things change with the kinetics observed here.

Previously we mentioned briefly in the Discussion section the potential impact of the tRNA binding kinetics in the co-transcriptional setting. In the revised manuscript, we have significantly expanded such discussion as follows:

"T-box riboswitches fold and function co-transcriptionally in the cell, and hence we propose that a two-step kinetic model is kinetically beneficial during co-transcriptional folding of the T-box and sensing of the tRNA ligand. \[...\] Finally, the fully bound state has a lifetime of at least 24 s, allowing RNAP to elongate more than 1,000 nts before the tRNA dissociates. Therefore, the second binding step in the WT T-box with uncharged tRNA^Gly^ is close to irreversible in such biological setting."

> \- In general, the authors may undersell the two-step mechanism a bit. In what types of other systems (e.g., Cas9? Ago?) have two step binding mechanisms been observed? Is this potentially a general strategy for promoting fidelity? Would incorporating a proofreading/fidelity step be useful for thinking about biotechnology applications?

We thank the reviewers for this suggestion. We have now included discussion on two-step mechanisms utilized in other biological process as follows.

"Two-step binding mechanisms have been observed in a variety of protein or nucleic acid mediated biological process, including T-cell receptor (TCR) recognition of the major histocompatibility complex (MHC) presenting peptides, where TCRs scan the MHC scaffold first, followed by sensing of specific MHC-presenting peptides (Wu et al., 2002); interaction of the signal recognition particle (SRP) receptor with the membrane, where SRP receptors interact with the membrane in a dynamic mode followed by an SRP-induced conformational transition into a stable binding mode (Hwang Fu et al., 2017), DNA interrogation by CRISPR Cas9-crRNA, where Cas9-crRNA recognizes the protospacer adjacent motif (PAM) on the target DNA followed by sensing of the spacer sequence and triggering R-loop formation (Sternberg et al., 2014); and RNA-induced silencing complexes (RISCs) binding to their mRNA targets, where dynamic sampling of the "sub-seed" region occurs before targeting stably across the full seed region (Chandradoss et al., 2015; Herzog and Ameres, 2015; Salomon et al., 2015, 2016).

In all of these cases, a two-step binding mechanism provides a good balance between sensitivity and specificity."

> 3\) The labeling scheme employed in this work places a dye at the 5\'-terminus of tRNA. While qualitative, previous biochemical work (Zhang and Ferre-D\'Amare, (2014)) suggested intimate coaxial stacking between the antiterminator element of the T-box and the acceptor stem of tRNA. Thus, an important control experiment is to show that placing a dye at the 5\'-terminus of tRNA does not impact tRNA-T-box association, or to determine what the effect is. An ITC experiment (like the one authors' report, for other purposes, in Figure 3---figure supplement 2) would be pretty clear in this regard.

We thank the reviewers for this critical comment. We have performed ITC experiments on the binding of Cy5 labeled tRNA on the 5' end. This is not an easy experiment as it requires large amounts of labeled tRNA, but we succeeded in making it work. A revised figure (Figure 1---figure supplement 2) showing the new ITC result is now part of the manuscript with the experimental details in the figure caption and in the Materials and methods section. As expected, Cy5 placed at the 5' end the tRNA modestly affects binding, decreasing the binding constant by \~4 fold and suggesting that the fully bound state should be even more stable than measured. As the Cy5 dye is placed close to the NCCA end of the tRNA, the effect of the label should be limited to the second binding step. The fact that the k~1~ and k~-1~ of the first binding step in our study are highly consistent with the reported values by Suddala et al., also suggests that the label only affects the second binding step. Overall, the lifetime of the fully bound state is, as we indicate in the manuscript, underestimated not only due to fluorophore photobleaching, but also due to the 5' label. In this sense, the minor pitfall introduced by the label does not change the overall conclusions. We revised the Discussion section of the manuscript to include this.

"Without the NCCA interaction, the binding of tRNA is unstable, with a mean lifetime of \~4 s, whereas with interactions both with the anticodon and the NCCA end, the binding of tRNA is very stable, with a mean lifetime \> 24 s. It should be noted that the latter lifetime is likely to be much longer for two reasons: first, the measurement is limited by fluorophore photobleaching, which limits long measurements in our experiments; second, the Cy5 label placed at the 5' end of the tRNA reduces the overall binding affinity by \~ 4-fold (Figure 1---figure supplement 2), likely because the fluorophore impairs the NCCA/t-box interactions to some extent."

> 4\) The experiment establishing the kink-turn as the hinge point for the conformational change between the partially bound and full complex is on the weak side. The authors claim that the absence of a FRET change in their experiment is evidence that the kink-turn must be the point where flexing occurs. An alternative interpretation of this experiment could be that this just shows that the tRNA is not changing position relative to the anchor point during this transition, rather than pinpointing to where the T-box is bending to form the full complex. An experiment that gives a positive result upon kink-turn bending and full complex formation would be stronger evidence for the claim that the kink-turn is the main source of conformational change.

We thank the reviewers for pointing out this premature conclusion. We agree with the reviewers that insignificant FRET change between the 5' end of the tRNA and the base of Stem I is not sufficient to prove that the hinge is at the K-turn region. In order to provide positive evidence for this conclusion, the most straightforward way would be visualize the structures of the Tbox/tRNA complex at the partially bound and fully bound states, which is beyond the scope of the current study. However, as the reviewers suggest, our data show the 5' end of the tRNA maintains its distance, or configuration, relative to the base of the Stem I during the second binding step. In addition, the kinetics of the k-turn mutant indicate that the flexibility of the k-turn is very important for the transition from the partially bound to the fully bound state. Therefore, we decided to revise the change the subtitle of the related section and also the Discussion section in the manuscript to simply mentioning the possibility that the k-turn is likely to be the hinge region. the new subtitle reads:

"The NCCA end of the uncharged tRNA maintains its relative position to the K-turn region during the second binding step"

While the Discussion section was changed as follows:

"Based on the known structures of Stem I in complex with tRNA^Gly^ (Grigg and Ke, 2013; Zhang and Ferre-D\'Amare, 2013), it was hypothesized that the intra-T-box conformational change is likely to involve the K-turn region, which sits at the junction between the 5' and 3' portions of the T-box. Our observation that the NCCA end of the uncharged tRNA moves towards the anti-terminator stem (revealed by the T-box~182~-Cy3(3') and tRNA^Gly^-Cy5 FRET), but maintains its relative position to the K-turn region (revealed by the T-box~182~-Cy3(5') and tRNA^Gly^-Cy5 FRET) during the second binding step is consistent with the role of the K-turn region as the hinge of the intra-T-box conformational change."

*5) The authors conclude from their experiments that tRNA binding is a two-step process where the Stem-I interaction occurs first followed by the anti-terminator interaction. This is likely true* in vivo *where Stem-I emerges from the polymerase first. However, in their system the possibility exists that the anti-terminator interaction occurs first followed by Stem-I. Would the authors be able to discern FRET traces where this occurs using their set-up? Are transitions besides the.4 to.7 state observed? If the anti-terminator is never found to be bound first, can the authors provide a reason?*

We concluded that the two-step binding process samples the 0.4 FRET state first for the following two reasons: (1) due to the imaging time resolution, most of the traces showed singlestep FRET increases from zero to 0.7 during the flow experiment, where we can capture the realtime binding. Nevertheless, we still see traces showing sampling of the 0.4 FRET state before the 0.7 FRET. (2) Perhaps a stronger argument is that we did not observe any transient binding of tRNA^Tyr^, which has an intact and accessible NCCA, but not the correct anticodon. The latter observation supports the model that anticodon binding needs to occur before establishment of the NCCA interaction. We modified the manuscript to make the point more implicit.

"Collectively, our results suggest a two-step binding model involving the separate establishment of the interactions with the anticodon and the NCCA. The fact that tRNA^Tyr^, which has a mismatched anticodon, but contains an intact NCCA 3' end, does not show any binding activity suggest that interactions with the anticodon precede the interactions with the NCCA end of the tRNA and are necessary for the establishment of the NCCA contacts."

> 6\) Subsection "Binding of cognate tRNA by the glyQS T-box results in two distinct FRET states", it is unclear why some molecules are transitioning here, and others are not. In the recently published T-box paper from the Walter lab, Walter et al., stressed that their T-box was purified under native conditions. While in this work the RNA was denatured. How was the RNA refolded? Have the authors run a native gel of their RNA to detect possible folding heterogeneity that could explain some of these results?

We have added native gel electrophoresis analysis of the T-box folding as a supplement to Figure 1 (Figure 1---figure supplement 1). There is some folding heterogeneity in the T-box, but not in the tRNA, which is fully folded. The T-box constructs, including the WT and the mutants, all consistently show a 60-75% folding efficiency. Nevertheless, when we mix folded T-box with tRNA using a gel shift assay we do not observe tRNA binding to the misfolded/unfolded fraction or to the T-box that is not put through the refolding process. Therefore, we do not think the unfolded/misfolded fraction affects our smFRET measurement or data interpretation. We do not have a good explanation for the \~10% subpopulation that shows transient back transition into the partially bound state yet. Therefore, we do not provide any biological meaning for that small subpopulation.

> 7\) Subsection "Determination of kinetic parameters", can the authors provide additional information (or a reference or a simulation) for adjusting the fitted kinetic parameter based on the percentage of data observed? Does this really scale strictly as a percentage? How does the error in the fit scale?

We thank the reviewers for pointing this out and helping make our analysis more rigorous. We performed a Gillespie simulation on the observed signal as a function of k~1~ and k~-1~ during the first binding step, which is described in detail in the Materials and methods section. The observed signal in the simulation mimicked the experiment and imaging processing. The simulation shows that the fraction of molecules generating a binding signal is insensitive to k~-1~. The fraction does not scale linearly with apparent k~1~ within a range spanning 6 orders of magnitude (10^-7^ to 10^-1^ s^-1^); however, within the range of our experimental results, a linear relationship is still a good approximation (Pearson's R = 0.99, see figure below). Nevertheless, we decided to modify the k~1~ calculation with a better fit according to the simulation, as described in the Materials and methods section and add a new figure, Figure 5---figure supplement 5. The modified calculation gives very similar results to the previous calculation within the linear approximation, and therefore all conclusions regarding the effects of the mutations still hold.

[^1]: Innovation and Technology Transfer Division, Rush University Medical Center, Chicago, United States.

[^2]: These authors contributed equally to this work.
